# Queue

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/queue-2

- Industry: Healthcare IT
- Headquarters: Palo Alto, US
- Website: www.queue.inc
- Total disclosed funding: $13M
- Latest round: Seed (Jun 30, 2026)
- Investors on record: 5

## About

Based in the US, Queue provides an autonomous robotic pharmacy solution that automates prescription dispensing with maximum efficiency and zero human involvement.Queue was founded in 2025 and operates from Palo Alto, US. The company has raised a total of USD 6.00 mn in funding, with the latest round being led by Riot Ventures. Queue has completed 2 deals, primarily targeting the healthcare sector with its innovative pharmacy automation solutions.Queue specializes in developing the world's first fully autonomous robotic pharmacy, which automates the dispensing and verification of prescriptions without human involvement. Their core product is a dispensing unit capable of handling sealed wholesale bottles and producing verified prescription vials at a high rate, addressing critical issues like long patient wait times and pharmacy closures in the US. Queue serves retail pharmacy locations, hospitals, and underserved communities, ensuring that commonly prescribed medications are readily available through customizable inventory management.Queue generates revenue through a B2B model, deploying autonomous pharmacy units in partnerships with retail stores, hospitals, and healthcare systems. Revenue streams include direct sales of robotic units and potential ongoing revenue from software and maintenance agreements post-installation. Each unit is designed to stock 250 to 280 of the most prescribed drugs, optimizing the dispensing process for improved operational efficiency and patient experience.Queue raised USD 6.00 mn in pre-seed funding led by Riot Ventures. The company plans to utilize the new funding to enhance its technology and expand its operations into new markets, focusing specifically on underserved regions where pharmacy access is limited. Upcoming product launches include advanced versions of their autonomous pharmacy units, expected to be available in the next 12 months, aimed at improving efficiency and patient care.

## Funding rounds

- Seed, Jun 30, 2026, $13M — Ubiquity Ventures, AlleyCorp, Banter Capital, Grep VC, House Capital

## Investors

- Ubiquity Ventures (https://capitalatlas.ai/funds/ubiquity-ventures) — Seed
- AlleyCorp — Seed
- Banter Capital (https://capitalatlas.ai/funds/banter-capital) — Seed
- Grep VC (https://capitalatlas.ai/funds/grep-vc) — Seed
- House Capital (https://capitalatlas.ai/funds/house-capital) — Seed